Pain Management

About Conference

8th International Conference and Exhibition on Pain Management

May 21–22, 2026 | Paris, France

Theme: “Redefining Pain: Precision Therapies, NeuroTech & Holistic Healing for a Pain-Free Future”

Join us at the 8^th International Conference and Exhibition on Pain Management, hosted by Conference Series, where global healthcare leaders, researchers, academicians, clinicians, and industry innovators will converge in the beautiful city of Paris, France, from May 21–22, 2026.

This conference serves as a dynamic platform for engagement, empowerment, evolution, and exploration of next-generation strategies in pain assessment, therapy, technology, and patient care. With a focus on precision medicine, digital pain solutions, opioid alternatives, and integrative therapies, the conference will provide a transformative space for advancing knowledge and clinical expertise across disciplines.

The 2026 edition builds upon the success of previous years, offering a comprehensive scientific program featuring plenary sessions, panel discussions, workshops, poster presentations, and an interactive exhibition. Attendees will gain practical insights into real-world challenges and innovative solutions in anaesthesia, pain medicine, rehabilitation, and palliative care.

Target Audience:

• Anesthesiologists & Pain Medicine Specialists
• Critical Care & ICU Nurses
• Physiotherapists, Psychologists & Pain Therapists
• Neuroscience and Neuromodulation Researchers
• Rehabilitation Professionals
• Palliative and Supportive Care Experts
• Clinical Pharmacists & Medical Officers
• Healthcare Technology Providers
• Medical Device Manufacturers
• Students, Scholars & Research Fellows
• Industry Leaders and Entrepreneurs

Reasons to Attend:

• Showcase and publish your research in an international forum
• Learn the latest in pain diagnostics, pharmacology, and non-pharmacologic interventions
• Explore novel technologies including AI, VR, neuromodulation, and regenerative therapies
• Participate in pre-conference workshops and live demonstrations
• Network with global experts, innovators, and decision-makers
• Visit our interactive exhibition featuring emerging tools, techniques, and industry leaders
• Compete for Best Poster and Young Researcher awards

Don't miss this opportunity to shape the future of pain care through innovation, collaboration, and knowledge sharing.
Let’s work together to redefine the experience of pain—and the possibilities for healing.

Session & Tracks

1. Chronic Pain Management

Chronic pain, lasting longer than three months, often persists beyond typical healing and significantly impacts quality of life. Managing chronic pain requires a multidisciplinary approach that includes medical treatment, physical therapy, psychological support, and lifestyle interventions. Current research emphasizes individualized care plans tailored to the type and cause of pain, such as back pain, arthritis, or fibromyalgia. Advances in pharmacologic options, neuromodulation, and non-pharmacological strategies like mindfulness and cognitive-behavioural therapy are reshaping treatment standards. Effective chronic pain management focuses not only on symptom relief but also on improving daily function, emotional well-being, and social participation.

Societies: Alliance of State Pain Initiatives | American Academy of Hospice and Palliative Medicine | American Academy of Orofacial Pain | American Academy of Pain Management | American Academy of Pain Medicine

2. Neuropathic Pain

Neuropathic pain arises from damage or dysfunction in the nervous system and is often described as burning, stabbing, or tingling. Conditions such as diabetes, shingles, multiple sclerosis, and spinal cord injuries are common causes. Unlike nociceptive pain, neuropathic pain can be more challenging to treat and may require combinations of anticonvulsants, antidepressants, topical agents, and nerve blocks. Research continues to explore targeted molecular therapies, gene modulation, and neuroplasticity-based interventions. Understanding the mechanisms behind nerve injury and repair is essential for developing more precise and effective treatment strategies.

Societies: American Society of Regional Anesthesia and Pain Medicine | Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

3. Musculoskeletal Pain

Musculoskeletal pain affects the bones, joints, muscles, ligaments, and tendons and can be acute or chronic. It may result from injury, overuse, postural strain, or underlying disorders like arthritis or fibromyalgia. Common types include back pain, neck pain, and joint discomfort. Management strategies often involve a combination of physical therapy, pharmacologic treatment (e.g., NSAIDs, muscle relaxants), lifestyle modification, and ergonomic education. Interventional procedures such as joint injections and dry needling may be beneficial in persistent cases. Exercise-based rehabilitation and manual therapy are widely recommended for long-term recovery. A multidisciplinary approach is essential for improving mobility and reducing pain-related disability.

Societies: American Board of Pain Medicine | American Chronic Pain Association | American Society of Anesthesiologists | American Society of Paranaesthesia Nurses | American Society of Regional Anesthesia and Pain Medicine

4. Cancer and Palliative Pain

Pain in cancer patients can arise from tumours, treatments (like surgery or chemotherapy), or related complications. Palliative pain management aims to relieve suffering and enhance quality of life, particularly for those with advanced or terminal conditions. Approaches include opioids, adjuvant medications, nerve blocks, and integrative therapies such as massage or acupuncture. Psychological support is also vital, addressing the emotional and existential aspects of living with chronic illness. Advances in oncology and pain science are enabling more precise and compassionate pain relief strategies. The goal is to provide comfort, dignity, and holistic care tailored to individual patient needs.

Societies: Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

5. Interventional Pain Techniques

Interventional pain techniques involve minimally invasive procedures aimed at diagnosing or treating specific pain sources. These include nerve blocks, epidural injections, radiofrequency ablation, spinal cord stimulation, and facet joint interventions. Often used when conservative treatments fail, these procedures offer targeted relief and can reduce reliance on long-term medication. Interventional approaches are especially effective for conditions like sciatica, complex regional pain syndrome, and facet joint arthritis. Ongoing advancements in imaging, neuromodulation, and regenerative technologies continue to refine these techniques, increasing safety and efficacy. A thorough patient evaluation is essential to determine suitability and optimize outcomes.

Societies: American Society of Regional Anesthesia and Pain Medicine | Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

6. Regenerative Therapies and Stem Cells

Regenerative medicine focuses on repairing or replacing damaged tissues to restore function and reduce pain. In pain management, therapies like platelet-rich plasma (PRP), mesenchymal stem cells, and prolotherapy are being explored for conditions such as osteoarthritis, tendon injuries, and disc degeneration. These treatments aim to stimulate the body’s natural healing mechanisms, offering a potential alternative to surgery or long-term medication. While promising, many regenerative therapies are still under clinical investigation. Understanding mechanisms, optimizing delivery methods, and establishing standardized protocols are key to integrating these therapies into routine practice. Ethical and regulatory considerations also play a crucial role.

Societies: Alliance of State Pain Initiatives | American Academy of Hospice and Palliative Medicine | American Academy of Orofacial Pain | American Academy of Pain Management | American Academy of Pain Medicine

7. Headache and Migraine Management

Headaches, including migraines, tension-type, and cluster headaches, are among the most common neurological complaints worldwide. Migraine, in particular, is a disabling condition characterized by intense, recurring headaches often accompanied by nausea, aura, and sensitivity to light or sound. Management includes pharmacologic treatments like trip tans, CGRP inhibitors, and preventative medications, as well as lifestyle modifications, biofeedback, and cognitive therapies. Emerging therapies include neuromodulation devices and dietary interventions. Accurate diagnosis and individualized treatment are essential due to the variable nature of headache disorders. Ongoing research aims to uncover genetic, hormonal, and environmental triggers to enable more targeted interventions.

Societies: American Board of Pain Medicine | American Chronic Pain Association | American Society of Anesthesiologists | American Society of Paranaesthesia Nurses | American Society of Regional Anesthesia and Pain Medicine

8. Digital Health and AI in Pain Care

Digital health technologies are transforming how pain is assessed, monitored, and managed. Tools such as mobile health apps, wearable sensors, virtual reality, and telemedicine platforms enhance patient engagement and enable remote pain tracking. Artificial intelligence (AI) is being applied to pain diagnostics, risk prediction, and personalized treatment planning. Machine learning algorithms can analyse large datasets to identify pain patterns and optimize clinical decisions. These innovations increase accessibility, reduce healthcare disparities, and support data-driven care models. However, challenges remain in data privacy, validation, and integration into clinical workflows. Digital tools are poised to complement—not replace—traditional pain management methods.

Societies: American Society of Regional Anesthesia and Pain Medicine | Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

9. Opioid Alternatives and Pharmacological Innovations

In response to the opioid crisis, research into alternative pain medications has expanded significantly. Non-opioid analgesics, including NSAIDs, anticonvulsants, antidepressants, and topical agents, are being optimized for various pain conditions. Novel drugs targeting specific pain pathways—such as sodium channel blockers and monoclonal antibodies—offer promising avenues for relief with fewer side effects and addiction risks. Personalized medicine approaches, such as pharmacogenomics, are improving drug selection and dosing. The focus is shifting toward safer, more effective pharmacological options that prioritize long-term function and quality of life while minimizing harm and dependence.

Societies: Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

10. Rehabilitation and Physical Therapy in Pain

Rehabilitation and physical therapy play a crucial role in managing both acute and chronic pain. These non-invasive approaches focus on restoring movement, function, and strength through tailored exercise programs, manual therapy, and patient education. Physical therapists help patients develop coping strategies, improve posture, and prevent pain recurrence. Techniques like stretching, resistance training, hydrotherapy, and ultrasound therapy are commonly used. Rehabilitation also supports post-surgical recovery and helps reduce dependence on medications. An interdisciplinary approach that integrates physical therapy with behavioural and medical care has shown excellent outcomes in pain reduction and functional improvement. Personalized rehabilitation plans empower patients to take an active role in their recovery journey.

Societies: Alliance of State Pain Initiatives | American Academy of Hospice and Palliative Medicine | American Academy of Orofacial Pain | American Academy of Pain Management | American Academy of Pain Medicine

11. Pediatric and Geriatric Pain

Pain management in children and older adults presents unique challenges due to physiological, developmental, and communication differences. Pediatric pain is often under recognized and undertreated, necessitating child-specific assessment tools and treatments. In contrast, geriatric pain is commonly linked to degenerative diseases, polypharmacy, and cognitive decline, requiring careful medication management. Both age groups benefit from multimodal approaches combining pharmacologic, physical, and psychological therapies. Non-pharmacologic interventions like play therapy, distraction, or physical activity are vital in paediatrics, while geriatrics may require balance training and chronic disease management. Addressing pain effectively in these populations improves comfort, functionality, and quality of life.

Societies: Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

12. Psychological and Behavioural Pain Interventions

Psychological and behavioural therapies are essential for understanding and managing the emotional and cognitive aspects of pain. Techniques such as cognitive-behavioural therapy (CBT), mindfulness-based stress reduction, biofeedback, and acceptance and commitment therapy help patients cope with pain more effectively. These approaches aim to break the pain-anxiety-depression cycle, reduce pain-related distress, and improve coping skills. Behavioural strategies can also enhance adherence to medical treatments and promote healthier lifestyle habits. Psychological interventions are particularly beneficial for chronic pain sufferers, where physical causes alone may not explain ongoing discomfort. A holistic view that addresses both body and mind often leads to more sustainable pain relief.

Societies: American Board of Pain Medicine | American Chronic Pain Association | American Society of Anesthesiologists | American Society of Paranaesthesia Nurses | American Society of Regional Anesthesia and Pain Medicine

13. Neurostimulation and Neuromodulation

Neurostimulation and neuromodulation involve electrical or chemical stimulation of the nervous system to alter pain signalling. Techniques such as spinal cord stimulation, peripheral nerve stimulation, and transcutaneous electrical nerve stimulation (TENS) are used when conventional treatments are ineffective. These methods target specific nerve pathways to reduce pain perception, offering a minimally invasive and often reversible option for patients with conditions like neuropathic pain or failed back surgery syndrome. Advances in implantable devices, wireless technologies, and closed-loop systems are improving efficacy and patient comfort. Neuromodulation is a rapidly evolving field offering innovative solutions for complex and chronic pain syndromes.

Societies: Alliance of State Pain Initiatives | American Academy of Hospice and Palliative Medicine | American Academy of Orofacial Pain | American Academy of Pain Management | American Academy of Pain Medicine

14. Complementary and Integrative Pain Therapies

Complementary and integrative therapies encompass non-traditional treatments used alongside conventional medicine to enhance pain relief. These include acupuncture, massage therapy, yoga, chiropractic care, herbal medicine, and mind-body practices like meditation. These therapies aim to treat the whole person—physically, emotionally, and spiritually—by addressing the root causes of pain and promoting self-healing. Evidence supports their effectiveness for conditions such as lower back pain, osteoarthritis, and fibromyalgia. Integrative approaches are increasingly accepted in mainstream healthcare due to their potential to reduce medication use, improve well-being, and empower patients in their care. Personalization and practitioner expertise are key to optimal outcomes.

Societies: Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

15. Public Health Approaches to Pain Management

Pain is not only a medical issue but also a major public health challenge affecting millions globally. Public health strategies aim to prevent pain, reduce its societal impact, and ensure equitable access to care. These approaches involve community education, early intervention, policy development, and healthcare system improvements. Addressing social determinants of health, reducing stigma, and promoting evidence-based treatments are key components. Programs targeting safe opioid use, pain awareness, and workforce training help align healthcare systems with best practices. A public health framework encourages collaboration among clinicians, policymakers, and communities to build comprehensive, sustainable solutions for pain management.

Societies: American Society of Regional Anesthesia and Pain Medicine | Association of Anaesthetists of Great Britain and Ireland | Centre for Pediatric Pain Research | Chronic Pain Association of Canada | Pain Concern | Vulvar Pain Foundation | Pain Relief Foundation

16. Anesthesia and Perioperative Pain Care

Anaesthesia plays a vital role in managing pain before, during, and after surgery. Perioperative pain care includes preoperative assessment, intraoperative anesthetic techniques, and postoperative pain control strategies. Effective management not only ensures patient comfort but also improves surgical outcomes and recovery times. Advances in regional anesthesia, multimodal analgesia, and opioid-sparing protocols are transforming how pain is addressed in surgical settings. Enhanced Recovery After Surgery (ERAS) protocols highlight the importance of coordinated, evidence-based care. Anesthesiologists work closely with surgical teams to tailor pain control plans, emphasizing patient safety, minimized side effects, and quicker rehabilitation.

Societies: American Board of Pain Medicine | American Chronic Pain Association | American Society of Anesthesiologists | American Society of Paranaesthesia Nurses | American Society of Regional Anesthesia and Pain Medicine

17. Innovations in Pain Education and Clinical Training

Education and training are central to advancing pain management practice. Innovative models focus on interprofessional learning, evidence-based curricula, and patient-centred care. Simulation training, digital learning platforms, and immersive case-based education help clinicians develop essential pain assessment and management skills. There is growing emphasis on training that incorporates psychological, cultural, and social aspects of pain. Bridging the gap between research and clinical practice through continuous professional development ensures that healthcare providers are equipped with the latest tools and strategies. Empowering practitioners with advanced education leads to improved patient outcomes and more compassionate, informed care.

Societies: Alliance of State Pain Initiatives | American Academy of Hospice and Palliative Medicine | American Academy of Orofacial Pain | American Academy of Pain Management | American Academy of Pain Medicine

Market Analysis

1. Pain Management Devices Market

• The global pain management devices market was valued at approximately USD?5.3?billion in 2024, and is projected to reach around?USD?13?billion by 2034, with a CAGR of ~9.4.

• Neurostimulation devices dominate the product landscape (accounting for 32–60% market share), driven by spinal cord stimulation and peripheral nerve stimulators used for neuropathic pain, fibromyalgia, and back pain.

• Among applications, neuropathic pain makes up the largest share (≈ 32%), while cancer-related pain is expected to be the fastest-growing segment due to rising cancer diagnoses.

• Hospitals and clinics accounted for the largest end?user segment (~31.9% in 2024), while physiotherapy and home-care settings are emerging as fast-growing end-use markets owing to convenience and rising demand for non-pharmacologic care

2. Regional Insights

• North America leads the world market with ~46–49% share, supported by advanced healthcare infrastructure, strong reimbursement systems, and high chronic pain prevalence among aging populations.

• Europe (e.g. Germany, France, UK) follows, with projected CAGR of ~5–6% through 2035.

• Asia-Pacific is the fastest-growing region, with notable growth in India and China (CAGR ≈ 7–8%) thanks to expanding healthcare access and rising disease burden

3. Pain Medications & the Shift Toward Non-Opioids

• The global pain treatment market (including drugs and devices) exceeded USD?75?billion in 2023, and is expected to surpass USD?130?billion by 2030, driven by rising chronic pain prevalence and demand for non-addictive therapies.

• Journavx (suzetrigine), a novel non-opioid analgesic approved by the U.S. FDA in January 2025, is recognized as the first new class of acute pain medication in two decades. Analysts estimate potential cumulative sales of USD 3.7?billion by 2030, with upside estimates up to USD?4–10?billion long?term, marking it as a game?changer in opioid?free acute pain management.

4. Strategic Drivers & Challenges

• Persistent public health concerns over opioid misuse and overdose have prompted stricter regulation and a search for safer alternatives, propelling growth in device-based and non-opioid pain therapies.

• Barriers include the high costs of advanced devices, implant-related complications, and limited acceptance in resource-limited areas. Reimbursement uncertainty also remains a constraint for novel pharmaceuticals like Journavx.

• Bioelectronic medicine and neuromodulation represent the future: precision, non-drug therapies targeting neural pathways are gaining investor and regulatory interest, with expectations to evolve into a multi?billion-dollar sector beyond traditional drug markets.

• Integration of digital tools (e.g., AI, VR, home-use wearables) is expanding access and monitoring capabilities, particularly in telehealth and physiotherapy settings.

• Growth in emerging markets—especially Asia, Latin America, and parts of Africa—offers opportunities for device makers and pharmaceutical companies to tap into underserved populations with rising chronic pain incidence.

Conclusion:

The pain management market is undergoing rapid transformation powered by device innovations, non-opioid pharmacotherapy, digital health adoption, and a shifting regulatory landscape. For stakeholders and event planners, these trends amplify the need to feature technology showcases, sessions on regulatory policy and reimbursement, and interdisciplinary collaboration between clinicians, researchers, and industry leaders.